Abstract
This report analyzes the worldwide markets for Cardiac Rhythm Management (CRM)
Devices in Millions of US$ by the following segments: Implantable Cardioverter
Defibrillators (ICD), Pacemakers, External Defibrillators, and EP
Catheterization, Mapping, and Ablation (CMA) devices.The report provides
separate comprehensive analytics for the United States, and Rest of World.
Annual forecasts are provided for each region for the period 2006 through
2015. A six-year historic analysis is also provided for these markets. The
report profiles 59 companies including many key and niche players worldwide
such as Bard Electrophysiology, Biosense Webster, Inc., Boston Scientific
Corporation, Biotronik GMBH & Co. KG, Medtronic, Inc., Medtronic CryoCath LP,
Vitatron Nederland BV, Philips Healthcare, St. Jude Medical, Inc., and Sorin
Group. Market data and analytics are derived from primary and secondary
research. Company profiles are mostly extracted from URL research and reported
select online sources.
|